Food News and Research

RSS

Hemp flour with decaffeinated green tea leaves could be used to develop gluten-free snack cracker

The market for gluten-free foods with functional properties is growing immensely across virtually all food categories on a global level. The need to replace wheat proteins, fibers, and minerals is very important in order to provide a better selection and more nutritious food for consumers that belong to this segment of the population.

18 Mar 2014

Infant feeding and activity behaviors believed to increase child's risk for obesity later in life

Most of the parents included in a new study reported some infant feeding and activity behaviors that are believed to increase a child's risk for obesity later in life.

18 Mar 2014

Researchers analyze existing cohort studies and randomized trials on coronary risk and fatty acid intake

A new study raises questions about current guidelines which generally restrict the consumption of saturated fats and encourage consumption of polyunsaturated fats to prevent heart disease. The research was published today, 18 March, in the journal Annals of Internal Medicine.

18 Mar 2014

New sweetener from tequila plant may aid diabetes, weight loss

A sweetener created from the plant used to make tequila could lower blood glucose levels for the 26 million Americans and others worldwide who have type 2 diabetes and help them and the obese lose weight, researchers said here today.

18 Mar 2014

Bisphenol A may promote prostate tumourigenesis

Bisphenol A, an organic compound that is ubiquitous in plastic products, may have a direct tumourigenic effect in the prostate, US researchers have shown.

17 Mar 2014

Research on diverse health benefits of oats in protecting heart

Eleven top scientists from around the globe presented the latest findings on the powerful compounds found in oats in a scientific session titled, Physicochemical Properties and Biological Functionality of Oats, at the 247th Annual Conference of the American Chemical Society in Dallas, TX

17 Mar 2014

Sensient Technologies files definitive proxy materials with SEC, sends letter to shareholders

Sensient Technologies Corporation announced today that it filed definitive proxy materials with the Securities and Exchange Commission (the "SEC") in connection with its 2014 Annual Meeting of Shareholders, to be held on April 24, 2014.

17 Mar 2014

First Edition: March 17, 2014

Today's headlines include reports about new health coverage rules and guidances announced by the Obama administration.

17 Mar 2014

Scientists develop new water purifier that could work with sunlight

Sunlight plus a common titanium pigment might be the secret recipe for ridding pharmaceuticals, pesticides and other potentially harmful pollutants from drinking water.

17 Mar 2014

Edison Pharmaceuticals begins EPI-743 clinical trial in children with Pearson syndrome

Edison Pharmaceuticals today announced the initiation of a phase 2 study entitled "A Phase 2 Safety and Efficacy Study of EPI-743 (Vincerinone™) in Children with Pearson Syndrome." The Investigative New Drug application (IND) was approved by the Food and Drug Administration, Office of Hematology and Oncology Products.

17 Mar 2014

FDA grants Fast Track designation to Edison’s lead drug EPI-743

Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.

17 Mar 2014

Study suggests effective therapeutics for IBD may hinge on targeting GM-CSF axis

The protein GM-CSF plays a critical role in maintaining immune tolerance in the gut, with defects in the protein increasing the susceptibility to inflammatory bowel diseases (IBD), according to a new mouse study by a team of researchers from the Icahn School of Medicine at Mount Sinai.

17 Mar 2014

Merck's NOXAFIL injection gets FDA approval for intravenous use

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use.

16 Mar 2014

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery.

16 Mar 2014

Del Monte Foods joins Partnership for a Healthier America to end childhood obesity crisis

Del Monte Foods announced today it has joined the Partnership for a Healthier America, which works with the private sector and PHA Honorary Chair First Lady Michelle Obama to end the childhood obesity crisis, in a five-year commitment to help increase fruit and vegetable consumption among children.

14 Mar 2014

Derma Sciences' net sales increase 3% to $20.7 million in fourth quarter 2013

Derma Sciences, Inc., a tissue regeneration and burn care company focused on advanced wound care, today reported financial and operating results for the three months and year ended December 31, 2013.

14 Mar 2014

Most parents fail to see obesity in their children

Susann Regber has worked for many years with children with obesity as a pediatric nurse. In her dissertation at Sahlgrenska Academy, University of Gothenburg, she studied the parents' role in the health-promoting and disease-prevention work against child obesity in young children.

14 Mar 2014

Bariatric surgery may reduce knee pain in elevated BMI patients

There is a known link between elevated body mass index (BMI) and symptomatic knee osteoarthritis (OA). While patients who have undergone gastric bypass surgery (GBS)-a procedure that closes off much of the stomach and causes food to bypass a portion of the small intestine─typically lose weight, the comparative impact of this weight loss on knee pain and function has not been measured.

14 Mar 2014

Researcher discover new chemical class that attacks two key cancer cell building block targets

Imagine cutting down the growth of cancer cells at their earliest stages to halt tumor growth. Research conducted by leading cancer metabolism researchers at Stony Brook University, Paul M. Bingham, PhD, and Zuzana Zachar, PhD, is showing promise in this approach with their clinical investigation of a new class of compounds that disrupt cancer cell mitochondrial metabolism.

14 Mar 2014

MD Anderson collaborates with MedImmune to develop therapies that unleash patients' immune systems to attack cancers

The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers.

14 Mar 2014

Food News and Research

Hemp flour with decaffeinated green tea leaves could be used to develop gluten-free snack cracker

Infant feeding and activity behaviors believed to increase child's risk for obesity later in life

Researchers analyze existing cohort studies and randomized trials on coronary risk and fatty acid intake

New sweetener from tequila plant may aid diabetes, weight loss

Bisphenol A may promote prostate tumourigenesis

Research on diverse health benefits of oats in protecting heart

Sensient Technologies files definitive proxy materials with SEC, sends letter to shareholders

First Edition: March 17, 2014

Scientists develop new water purifier that could work with sunlight

Edison Pharmaceuticals begins EPI-743 clinical trial in children with Pearson syndrome

FDA grants Fast Track designation to Edison’s lead drug EPI-743

Study suggests effective therapeutics for IBD may hinge on targeting GM-CSF axis

Merck's NOXAFIL injection gets FDA approval for intravenous use

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Del Monte Foods joins Partnership for a Healthier America to end childhood obesity crisis

Derma Sciences' net sales increase 3% to $20.7 million in fourth quarter 2013

Most parents fail to see obesity in their children

Bariatric surgery may reduce knee pain in elevated BMI patients

Researcher discover new chemical class that attacks two key cancer cell building block targets

MD Anderson collaborates with MedImmune to develop therapies that unleash patients' immune systems to attack cancers

The future is bioengineered: Synthetic biology and global sustainability eBook

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News